Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Health & Wellness

Lung Health and Screening Program

We now offer CT scan lung screenings proven to detect cancer early

New Guidelines

Low-dose CT screening for lung cancer now available starting at age 50 with a 20 “pack-years” smoking history*.

*Reduced from age 55 and a 30 pack years” smoking history.

This screening can help detect lung cancer at an early stage in current or former heavy smokers.

The U.S. Preventive Services Task Force (UPSTF) recommends annual screening for lung cancer with low-dose computed tomography in high-risk individuals (Grade B recommendation). As part of our ongoing commitment to preventive care, ChristianaCare now offers lung screenings for your patients who have a history of heavy smoking. Our Lung Health and Screening Program offers:

  • A dedicated nurse navigator to assist with the entire screening process, from scheduling to following up with test results.
  • A low-dose CT lung scan–a protocol that was found to be effective in the National Lung Screening Trial (NLST) performed according to the American College of Radiology guidelines.
  • A multidisciplinary team, when appropriate, to assist with abnormal findings, referrals and follow-up.

You may qualify for the lung cancer screening if you:

  • Are 50 through 80 years of age AND
  • Have a history of heavy smoking* AND
  • Are current smoker or quit smoking within the last 15 years AND
  • Haven’t received a CT scan of the lungs in the past 12 months.

*Heavy smoking is defined as a smoking history of 20 “pack years” or more. A “pack year” is smoking an average of one pack of cigarettes per day for one year. For example, a person could have a 20 pack-year history by smoking one pack a day for 20 years or two packs a day for 10 years.

Additional information:

American Cancer Society

American Lung Association

For more information or to sign up for an appointment with the Nurse Navigator, click the registration button or call 302-623-CARE (2273).

Register online